Exploring RNAi as a therapeutic strategy for controlling disease in aquaculture

Paula Lima, James Harris, Mathew Cook

    Research output: Contribution to journalReview articlepeer-review

    34 Citations (Scopus)


    Aquatic animal diseases are one of the most significant constraints to the development and management of aquaculture worldwide. As a result, measures to combat diseases of fish and shellfish have assumed a high priority in many aquaculture-producing countries. RNA interference (RNAi), a natural mechanism for post-transcriptional silencing of homologous genes by double-stranded RNA (dsRNA), has emerged as a powerful tool not only to investigate the function of specific genes, but also to suppress infection or replication of many pathogens that cause severe economic losses in aquaculture. However, despite the enormous potential as a novel therapeutical approach, many obstacles must still be overcome before RNAi therapy finds practical application in aquaculture, largely due to the potential for off-target effects and the difficulties in providing safe and effective delivery of RNAi molecules in vivo. In the present review, we discuss the current knowledge of RNAi as an experimental tool, as well as the concerns and challenges ahead for the application of such technology to combat infectious disease of farmed aquatic animals. Crown

    Original languageEnglish
    Pages (from-to)729-743
    Number of pages15
    JournalFish and Shellfish Immunology
    Issue number3
    Publication statusPublished - Mar 2013


    Dive into the research topics of 'Exploring RNAi as a therapeutic strategy for controlling disease in aquaculture'. Together they form a unique fingerprint.

    Cite this